Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis

Translational Research

Volumn 149, Issue 3, 2007, Pages 107-113

  Lapierre, Pascal ^a   Béland, Kathie ^a   Alvarez, Fernando ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; LIVER ANTIGEN;

ANIMAL TISSUE; APOPTOSIS; AUTOIMMUNE HEPATITIS; CD8+ T LYMPHOCYTE; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOPTOSIS; HEPATITIS, AUTOIMMUNE; HEPATOCYTES; HUMANS; IMMUNE TOLERANCE;

EID: 33847057731     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2006.11.010     Document Type: Review

References (67)

1. Johnson P.J., and McFarlane I.G. Meeting report: International Autoimmune Hepatitis Group. Hepatol 18 (1993) 998-1005
2. Alvarez F. Autoimmune hepatitis. In: Suchy F., Sokol R.J., and Baliestreri W. (Eds). Liver disease in childhood (2001), Lippincott, Williams and Wilkins, New York
3. Krawitt E.L. Autoimmune hepatitis. N Engl J Med 354 (2006) 54-66
4. Homberg J.C., Abuaf N., Bernard O., Islam S., Alvarez F., Khalil S.H., et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatol 7 (1987) 1333-1339
5. Maggiore G., Bernard O., Homberg J.C., Hadchouel M., Alvarez F., Hadchouel P., et al. Liver disease associated with anti-liver-kidney microsome antibody in children. J Pediatr 108 (1986) 399-404
6. Maggiore G., Veber F., Bernard O., Hadchouel M., Homberg J.C., Alvarez F., et al. Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr 17 (1993) 376-381
7. Gregorio G.V., Portmann B., Reid F., Donaldson P.T., Doherty D.G., McCartney M., et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatol 25 (1997) 541-547
8. Djilali-Saiah I., Renous R., Caillat-Zucman S., Debray D., and Alvarez F. Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients. J Hepatol 40 (2004) 904-909
9. Gueguen M., Boniface O., Bernard O., Clerc F., Cartwright T., and Alvarez F. Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney microsome antibody. J Autoimmun 4 (1991) 607-615
10. Yamamoto A.M., Cresteil D., Boniface O., Clerc F.F., and Alvarez F. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1). Eur J Immunol 23 (1993) 1105-1111
11. Manns M.P., Johnson E.F., Griffin K.J., Tan E.M., and Sullivan K.F. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 83 (1989) 1066-1072
12. Martini E., Abuaf N., Cavalli F., Durand V., Johanet C., and Homberg J.C. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatol 8 (1988) 1662-1666
13. Abuaf N., Johanet C., Chretien P., Martini E., Soulier E., Laperche S., et al. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatol 16 (1992) 892-898
14. Lapierre P., Hajoui O., Homberg J.C., and Alvarez F. Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterol 116 (1999) 643-649
15. Lohr H.F., Schlaak J.F., Lohse A.W., Bocher W.O., Arenz M., Gerken G., et al. Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatol 24 (1996) 1416-1421
16. Lunardi C., Tiso M., Borgato L., Nanni L., Millo R., De Sandre G., et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol 28 (1998) 936-948
17. Wucherpfennig K.W., and Strominger J.L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80 (1995) 695-705
18. Marceau G., Lapierre P., Beland K., Soudeyns H., and Alvarez F. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?. Hepatol 42 (2005) 675-682
19. Djilali-Saiah I., Lapierre P., Vittozi S., and Alvarez F. DNA vaccination breaks tolerance for a neo-self antigen in liver: a transgenic murine model of autoimmune hepatitis. J Immunol 169 (2002) 4889-4896
20. von Herrath M.G., Evans C.F., Horwitz M.S., and Oldstone M.B. Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system. Immunol Rev 152 (1996) 111-143
21. Lapierre P., Johanet C., and Alvarez F. Characterization of the B cell response of patients with anti-liver cytosol autoantibodies in type 2 autoimmune hepatitis. Eur J Immunol 33 (2003) 1869-1878
22. Lapierre P., Djilali-Saiah I., Vitozzi S., and Alvarez F. A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens. Hepatol 39 (2004) 1066-1074
23. Lapierre P., Beland K., Djilali-Saiah I., and Alvarez F. Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development. J Autoimmun 26 (2006) 82-89
24. Lang K.S., Recher M., Junt T., Navarini A.A., Harris N.L., Freigang S., et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 11 (2005) 138-145
25. Kuniyasu Y., Marfani S.M., Inayat I.B., Sheikh S.Z., and Mehal W.Z. Kupffer cells required for high affinity peptide-induced deletion, not retention, of activated CD8+ T cells by mouse liver. Hepatol 39 (2004) 1017-1027
26. Bowen D.G., McCaughan G.W., and Bertolino P. Intrahepatic immunity: a tale of two sites?. Trends Immunol 26 (2005) 512-517
27. Mehal W.Z., Juedes A.E., and Crispe I.N. Selective retention of activated CD8+ T cells by the normal liver. J Immunol 163 (1999) 3202-3210
28. Warren A., Le Couteur D.G., Fraser R., Bowen D.G., McCaughan G.W., and Bertolino P. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatol 44 (2006) 1182-1190
29. John B., and Crispe I.N. Passive and active mechanisms trap activated CD8+ T cells in the liver. J Immunol 172 (2004) 5222-5229
30. Bertolino P., Schrage A., Bowen D.G., Klugewitz K., Ghani S., Eulenburg K., et al. Early intrahepatic antigen-specific retention of naive CD8+ T cells is predominantly ICAM-1/LFA-1 dependent in mice. Hepatol 42 (2005) 1063-1071
31. Bonder C.S., Norman M.U., Swain M.G., Zbytnuik L.D., Yamanouchi J., Santamaria P., et al. Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1. Immunity 23 (2005) 153-163
32. Edwards S., Lalor P.F., Nash G.B., Rainger G.E., and Adams D.H. Lymphocyte traffic through sinusoidal endothelial cells is regulated by hepatocytes. Hepatol 41 (2005) 451-459
33. Lalor P.F., Edwards S., McNab G., Salmi M., Jalkanen S., and Adams D.H. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J Immunol 169 (2002) 983-992
34. Beland K., Lapierre P., Djilali-Saiah I., and Alvarez F. Characterization of lymphocyte-mediated hepatocyte injury mechanisms in a murine model of autoimmune hepatitis. Can J Gastroenterol (2005) 19(C):R.0820.
35. Godessart N., and Kunkel S.L. Chemokines in autoimmune disease. Curr Opin Immunol 13 (2001) 670-675
36. Eksteen B., Grant A.J., Miles A., Curbishley S.M., Lalor P.F., Hubscher S.G., et al. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med 200 (2004) 1511-1517
37. Patel D.D., Zachariah J.P., and Whichard L.P. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol 98 (2001) 39-45
38. Ashhab Y., Dominguez O., Sospedra M., Roura-Mir C., Lucas-Martin A., and Pujol-Borrell R. A one-tube polymerase chain reaction protocol demonstrates CC chemokine overexpression in Graves' disease glands. J Clin Endocrinol Metab 84 (1999) 2873-2882
39. Buckley C.D., Amft N., Bradfield P.F., Pilling D., Ross E., Arenzana-Seisdedos F., et al. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol 165 (2000) 3423-3429
40. Dubois-Laforgue D., Hendel H., Caillat-Zucman S., Zagury J.F., Winkler C., Boitard C., et al. A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes 50 (2001) 1211-1213
41. Cuello C., Palladinetti P., Tedla N., Di Girolamo N., Lloyd A.R., McCluskey P.J., et al. Chemokine expression and leucocyte infiltration in Sjogren's syndrome. Br J Rheumatol 37 (1998) 779-783
42. Franciotta D., Martino G., Zardini E., Furlan R., Bergamaschi R., Andreoni L., et al. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J Neuroimmunol 115 (2001) 192-198
43. Qu P., Ji R.C., and Kato S. Expression of CCL21 and 5'-Nase on pancreatic lymphatics in nonobese diabetic mice. Pancreas 31 (2005) 148-155
44. Fukumoto N., Shimaoka T., Fujimura H., Sakoda S., Tanaka M., Kita T., et al. Critical roles of CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in the pathogenesis of both acute and adoptive transfer experimental autoimmune encephalomyelitis. J Immunol 173 (2004) 1620-1627
45. Kaneko H., Ogasawara H., Naito T., Akimoto H., Lee S., Hishikawa T., et al. Circulating levels of beta-chemokines in systemic lupus erythematosus. J Rheumatol 26 (1999) 568-573
46. Christen U., McGavern D.B., Luster A.D., von Herrath M.G., and Oldstone M.B. Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol 171 (2003) 6838-6845
47. Boven L.A., Montagne L., Nottet H.S., and De Groot C.J. Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions. Clin Exp Immunol 122 (2000) 257-263
48. Simpson J., Rezaie P., Newcombe J., Cuzner M.L., Male D., and Woodroofe M.N. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. J Neuroimmunol 108 (2000) 192-200
49. Narumi S., Takeuchi T., Kobayashi Y., and Konishi K. Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus. Cytokine 12 (2000) 1561-1565
50. Weninger W., and von Andrian U.H. Chemokine regulation of naive T cell traffic in health and disease. Semin Immunol 15 (2003) 257-270
51. Grant A.J., Goddard S., Ahmed-Choudhury J., Reynolds G., Jackson D.G., Briskin M., et al. Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol 160 (2002) 1445-1455
52. Leroy V., Vigan I., Mosnier J.F., Dufeu-Duchesne T., Pernollet M., Zarski J.P., et al. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatol 38 (2003) 829-841
53. Wald O., Pappo O., Safadi R., Dagan-Berger M., Beider K., Wald H., et al. Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus. Eur J Immunol 34 (2004) 1164-1174
54. Heydtmann M., Lalor P.F., Eksteen J.A., Hubscher S.G., Briskin M., and Adams D.H. CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol 174 (2005) 1055-1062
55. Ajuebor M.N., Aspinall A.I., Zhou F., Le T., Yang Y., Urbanski S.J., et al. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells. J Immunol 174 (2005) 8027-8037
56. Moreno C., Gustot T., Nicaise C., Quertinmont E., Nagy N., Parmentier M., et al. CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice. Hepatol 42 (2005) 854-862
57. Sato T., Thorlacius H., Johnston B., Staton T.L., Xiang W., Littman D.R., et al. Role for CXCR6 in recruitment of activated CD8+ lymphocytes to inflamed liver. J Immunol 174 (2005) 277-283
58. Gerard C., and Rollins B.J. Chemokines and disease. Nat Immunol 2 (2001) 108-115
59. Masuichi H., Seki S., Kitada T., Kawada N., Sakaguchi H., Nakatani K., et al. Significant role of apoptosis in type-1 autoimmune hepatitis. Osaka City Med J 45 (1999) 61-79
60. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., et al. Two CD95 (APO-1/Fas) signaling pathways. Embo J 17 (1998) 1675-1687
61. Galle P.R., Hofmann W.J., Walczak H., Schaller H., Otto G., Stremmel W., et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182 (1995) 1223-1230
62. Schlosser S.F., Azzaroli F., Dao T., Hingorani R., Nicholas Crispe I., and Boyer J.L. Induction of murine hepatocyte death by membrane-bound CD95 (Fas/APO-1)-ligand: characterization of an in vitro system. Hepatol 32 (2000) 779-785
63. Liu Z.X., Govindarajan S., Okamoto S., and Dennert G. Fas- and tumor necrosis factor receptor 1-dependent but not perforin-dependent pathways cause injury in livers infected with an adenovirus construct in mice. Hepatol 31 (2000) 665-673
64. Adachi K., Tsutsui H., Kashiwamura S., Seki E., Nakano H., Takeuchi O., et al. Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J Immunol 167 (2001) 5928-5934
65. Abougergi M.S., Gidner S.J., Spady D.K., Miller B.C., and Thiele D.L. Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infection. Hepatol 41 (2005) 97-105
66. Zender L., Hutker S., Mundt B., Waltemathe M., Klein C., Trautwein C., et al. NFκB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis. Hepatol 41 (2005) 280-288
67. Bowen D.G., Warren A., Davis T., Hoffmann M.W., McCaughan G.W., Fazekas de St Groth B., et al. Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8 T-cell activation by bone marrow-derived cells. Gastroenterol 123 (2002) 1252-1264